Mouth Cancer

• CLINICAL_TRIALS trial_result · 2023-08-03
  Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]

  Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.

• CLINICAL_TRIALS research · 2013-08-26
  Clinical Trial Update: Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx [Phase 3]

  A Phase 3 study evaluating whether adding interleukin-2 to surgery and radiation improves outcomes for mouth and oropharyngeal cancers; the …